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INTRODUCTION
The free radical gas nitric oxide (NO) is a recently identified neuronal
messenger that carries out diverse signaling tasks in both the central and
peripheral nervous systems. Whereas most neurotransmitters are packaged in
synaptic vesicles and secreted in a Ca2+-dependent manner from specialized
nerve endings, NO is an unconventional transmitter which is not packaged in
vesicles, but rather diffuses from its site of production in the absence of any
specialized release machinery. The lack of a requirement for release apparatus
raises the possibility that NO can be released from both pre- and postsynaptic
neuronal elements, In addition, because NO is gaseous and extremely
membrane permeant, it can bypass normal signal transduction routes involving
interactions with synaptic membrane receptors. Although the targets of NO
have not yet been completely described, it is known that NO can bind to the
iron contained in heine groups, leading to conformational changes in
associated proteins, such as guanylyl cyclase.
NO as an Intercellular Signaling Molecule
The idea that NO may participate in modulating neuronal function originally
arose from the discovery that it is an important intercellular signal that
maintains vascular tone and resistance. It had long been known that acetyl-
choline (Ach), as well as many other neurotransmitters and neuromodulators,
when applied to arteries or veins was capable of producing relaxations of the
smooth muscle. In 1980, Furchgott & Zawadski reported that the ACh-induced
153
www.annualreviews.org/aronline
Annual Reviews
A
nn
u.
 R
ev
. N
eu
ro
sc
i. 
19
94
.1
7:
15
3-
18
3.
 D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
154 SCHUMAN & MADISON
relaxation of rabbit aorta required the presence of endothelial cells. In an
elegant series of bioassays, endothelial cells were removed from the intimal
strip of rabbit aorta, and no relaxation could be elicited. The relaxation of the
muscle was then restored by the addition of exogenous endothelial cells. A
diffusible factor produced in endothelial cells, endothelial-derived relaxing
factor (EDRF), was proposed to account for the observed smooth muscle
relaxation. Further studies showed that the relaxation produced by ACh and
other agents was Ca2+-dependent (Griffith et al 1986). In addition, the
relaxation was thought to be mediated by rises in cGMP that were shown to
occur in the muscle but not in the endothelial cells (Rapoport et al 1983). 
was also known that several nitrovasodilators (agents that generate NO, e.g.
glyceryl trinitrate and sodium nitroprusside) did not require the presence of
endothelial cells to elicit relaxation. Thus, it was proposed that EDRF is NO,
based on the following observed similarities of NO and EDRF: both agents
are extremely labile (half-life = 4-6 s), the relaxations induced by both
substances are blocked by hemoglobin (which binds NO) or by generators 
O~-, and the effects of both NO and EDRF are enhanced by superoxide
dismutase, which scavenges superoxide ions. In 1987, two groups (Ignarro
et al 1987, Palmer et al 1987) directly demonstrated that the vascular
endothelium actually releases NO in quantities sufficient to account for the
biological activity of EDRF.
Since this initial discovery, NO has been implicated in several other
systems, including macrophage cytotoxicity (Marietta 1989), nonadrenergic
noncholinergic intestinal relaxation (Desai et al 1991), penile erection (Rajfer
et al 1992), neurotoxicity (Dawson et al 1991b), and plasticity in 
hippocampus (Bohme et al 1991, O’Dell et al 1991, Schuman & Madison
1991, Haley et al 1992) and cerebellum (Crepel & Jaillard 1990, Shibuki 
Okada 1990). The first demonstration of NO acting as a neuronal messenger
came from studies in cerebellar granule cells by Garthwaite and colleagues
(1988). These investigators demonstrated that the application of NMDA 
granule cells resulted in rises in cGMP levels that were blocked by both NO
synthase (NOS) inhibitors and hemoglobin, suggesting that NO was function-
ing as an intercellular messenger. These studies drew a significant amount of
attention to the signal transduction pathway involving NMDA receptors, NOS,
and guanylyl cyclase, and no doubt served as an impetus to many future
inquiries, in particular those regarding the role of NO in synaptic plasticity.
Although NO has recently been shown to function in a wide variety of central
and peripheral processes, this paper is limited to a brief review of NO and
NO synthase as well as a discussion of NO’s role in the modulation of synaptic
function in the following areas: NMDA receptor currents, neurotoxicity,
secretion, long-term depression and potentiation, and animal learning.
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NO AND SYNAPTIC FUNCTION 155
NITRIC OXIDE AND NITRIC OXIDE SYNTHASES
NOS Isoforms
Nitric oxide is produced by an NO synthase (NOS). To date, several different
nitric oxide synthases have been identified: one or more inducible NOSs
present in macrophages, neutrophils, hepatocytes, and possibly glial cells,
and at least two different constitutive forms present in endothelial cells and
neurons. Four distinct isoforms of NOS have been cloned thus far: a brain
NOS (Bredt et al 1991c), an endothelial NOS (Lamas et al 1992, Marsden 
al 1992, Sessa et al 1992), a macrophage NOS (Lowenstein et al 1992, Xie
et al 1992), and a hepatocyte NOS (Geller et al 1993). The different classes
of cloned enzymes hare about 50% identity in their amino acid sequences.
All forms of NOS characterized thus far require several electron donors [flavin
adeninedinucleotide (FAD), flavin mononucleotide (FMN), nicotinamide
adenine dinucleotide phosphate (NADPH), and tetrahydrobiopterin] and
produce NO by oxidizing one of the terminal guanidino nitrogens of
L-arginine, resulting in the stoichiometric production of L-citrulline (Figure
1).
Figure 1 Diagram of NO production at synapses. The calcium signal derived from the NMDA
receptor-channel, voltage-dependent Ca2+ channels (VDCC), or intracellular stores binds calmo-
dulin and activates the nitric oxide synthase (NOS). Activated NOS produces NO from L-arginine.
NO can then diffuse from its site of production to influence all nearby synapses.
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156 SCHUMAN & MADISON
The amino acid sequence of a brain NOS, originally purified from rat
cerebellum (Bredt & Snyder 1990), encodes a protein of 160 kD that contains
several recognition sites for required cofactoi’s, including a basic amphipathic
a helix calmodulin-binding consensus site, a cAMP-dependent protein kinase
phosphorylation consensus sequence, a NADPH-binding domain, and poten-
tial binding sites .for FMN and FAD (Bredt et al 1991a,c). The C-terminal
half of NOS shows substantial homology to rat cytochrome P-450 reductase
and sulphite reductase (Bredt et al 1991c), which also contain binding sites
for NADPH, FMN, and FAD. The full-length cDNA was inserted into an
expression vector and transfected into human kidney 293 cells. The expressed
NOS protein exhibited catalytic activity with properties corresponding to those
observed with the native NOS in cerebellum, namely a dependence on Ca2+
and NADPH and inhibition by calmodulin antagonists.
A family of endothelial NOSs has also been cloned, including a bovine
endothelial NOS (Lamas et al 1992, Sessa et al 1992) and a human NOS
(Janssens et al 1992, Marsden et al 1992). The deduced amino acid sequences
of both the bovine and human endothelial NOSs encode a protein of
approximate molecular mass 133 kDa, consistent with observed molecular
weight (135,000) of the purified protein (Pollock et al 1991). The sequences
of the two isoforms are highly homologous with one another (90%) and exhibit
50 and 60% homology with the cloned macrophage and brain NOS,
respectively. Like the brain NOS, the endothelial NOS also contains binding
regions for calmodulin, NADPH, FMN, and FAD, as well as a consensus
sequence for phosphorylation by cAMP-dependent protein kinase. Interest-
ingly, the endothelial NOS sequence also contains a consensus sequence for
myristylation at the amino terminus; as discussed below, this may account
for particulate localization of the endothelial NOS. The cloned cDNAs have
also been inserted into expression vectors and transiently expressed in COS
cells (Lamas et al 1992, Sessa et al 1992) or NIH3T3 cells (Janssens et 
1992). The transfected cells exhibited Ca2+-dependent conversion of L-argi-
nine to NO and citrulline that was sensitive to the NOS inhibitor L-NARG
or L-NAME.
Two apparently distinct isoforms of inducible NOS have been cloned: one
from macrophages (Lowenstein et al 1992, Lyons et al 1992, Xie et al 1992)
and one from human hepatocytes (Geller et al 1993). These two inducible
NOSs possess 80% amino acid sequence homology. The sequences of both
forms encode smaller proteins than the brain NOS; the approximate molecular
mass is 130 kD. As in other NOS isoforms, recognitions sites for FMN, FAD,
and NADPH are present. Although the activity of the macrophage NOS has
been observed to be largely Ca2÷- and calmodulin-independent, the enzyme
contains a recognition site for calmodulin binding. In human 293 kidney cells
transfected with the macrophage cDNA, the expression and activity’of
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NO AND SYNAPTIC FUNCTION 157
macrophage NOS was markedly enhanced by treatment with lipopolysaccha-
ride but was not affected by Ca2+ chelators (Lowenstein et al 1992). The
hepatocyte NOS also contains a calmodulin-binding domain. In contrast to
the macrophage NOS, however, the cloned hepatocyte NOS expressed in
human 293 kidney cells displayed an activity that was significantly attenuated
by both Ca2+ chelation and calmodulin antagonists (Geller et al 1993). Further
studies are obviously needed to explore the potential Ca2+- and calmodulin-
dependence of inducible NOS activity and to determine whether these two
cofactors might also play a role in modulating the expression of inducible
NOS.
Enzyme Activation
The expression of the inducible NOS requires protein synthesis and is initiated
by various cytokines and microbial products (Hibbs et al 1987, Stuehr 
Marletta 1987). Following induction, NO is produced in large quantities
(nanomoles) for several hours. In contrast, the constitutive NOS found 
blood vessels and in brain remains active for relatively short periods of time
and produces smaller quantities of NO (picomoles). This NOS is activated 
Ca2÷ that is bound to calmodulin (Knowles et al 1989, Bredt & Snyder 1990).
In the periphery, the primary source of Ca~+ may be agonist-induced
phosphoinositide (PI) hydrolysis resulting in inositol-triphosphate-mediated
release of Ca~+ from intracellular stores. In the brain, the flux of Ca2+ through
the NMDA receptor-channel has been implicated as the source of Ca2+ in
many systems, although it seems possible that influx of Ca2+ via voltage-sen-
sitive Ca2+ channels or release of Ca2+ from intracellular stores via neuro-
transmitter-induced PI hydrolysis (e.g. the metabotropic glutamate receptor)
may also activate the brain NOS (Figure 1).
Localization
The purification and cloning of the various NOS isozymes has prompted the
development of antibodies and antisense oligonucleotides that in turn have
permitted immunohistochemical mapping of NOS and localization of the NOS
mRNA by in situ hybridization. In addition, the histochemical marker
nitrotetrazolium blue (NTB) reacts with NOS-containing neurons (Dawson 
al 1991 a, Hope et al 1991). This reaction is accounted for by the redox activity
of NOS, which reduces nitrotetrazolium blue to NADPH diaphorase. In situ
hybridization (Bredt et al 1991b) for the brain NOS (originally purified from
cerebellum) reveals a high density of silver grains in the cerebellum, olfactory
bulb, and the pedunculopontine tegmental nucleus. In the pedunculopontine
tegmental area NOS-positive cells also contain choline acetyltransferase
(Dawson et al 1991a). Strong hybridization is also apparent in the hippocam-
pus (dentate gyrus), supraoptic nucleus, and superior and inferior colliculus.
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158 SCHUMAN & MADISON
Isolated NOS-containing neurons have been observed in the cerebral cortex
and the corpus striatum (Bredt et al 1991, Dawson et al 1991). These cells
also stain positive for somatostatin and neuropeptide Y (Vincent et al 1983,
Dawson et al 1991).
A matter of considerable debate concerns the localization of NOS in the
hippocampus and the cerebellum, two areas where NO has been implicated
in synaptic plasticity. Several studies (Bredt et al 1990, 1991b; Valtschanoff
et al 1993) have noted a lack of NOS immunoreactivity in rat CA1 pyramidal
neurons, the site where NO has been proposed to be produced during the
induction of long-term potentiation (O’Dell et al 1991, Schuman & Madison
1991). However, recent studies have reported that CA1 pyramidal neurons of
the hippocampus stain for NADPH diaphorase (Wallace & Fredens 1992) 
an NOS antibody (Schweizer et al 1993). Likewise, staining for NOS and
NADPH diaphorase has been observed in cerebellar granule cells and basket
cells, but has not been detected in Purkinje cells, where modification of
postsynaptic glutamate receptors has been proposed to underlie long-term
depression (LTD). This has led to the suggestion that during LTD, NO 
generated in other NOS-containing neurons in the cerebellar circuit. Of course,
the possibility remains that Purkinje cells express lower levels of NOS, which
have not been detected; alternatively, it is also possible that a different isoform
of brain NOS may be present in Purkinje neurons and CA1 pyramidal cells.
Regulation
The NOS isoforms may be regulated by several posttranslational forms of
modification, including phosphorylation and myristylation. Purified brain
NOS can be phosphorylated by cAMP-dependent protein kinase (Brune 
Lapetina 1991, Bredt et al 1992), protein kinase C (Nakane et al 1991, Bredt
et al 1992), and Ca2+/calmodulin-dependent protein kinase II (Nakane et 
1991, Bredt et al 1992, Schmidt et al 1992). The phosphorylation by all three
kinases occurs primarily on serine residues; each kinase predominantly
phosphorylates a distinct residue (Bredt et al 1992). The effects of phosphor-
ylation on NOS activity appear to be controversial: PKC has been reported
to both increase (Nakane et al 1991) and decrease (Bredt et al 1992) 
activity, cAMP-dependent protein kinase has been reported to have no effect
on NOS activity (Brune & Lapetina 1991, Bredt et al 1992). Phosphorylation
by Ca2+/calmodulin-dependent protein kinase has been reported to decrease
NOS activity (Nakane et al 1991, Schmidt et al 1992) or to have no effect
(Bredt et al 1992). The apparent discrepancies between these findings may
result from differing basal conditions used in the assays, including the presence
or absence of Ca2+ and/or calmodulin in the reaction mixtures. More studies
are needed to clarify the effects of phosphorylation on physiological NOS
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NO AND SYNAPTIC FUNCTION 159
activity and to explore the possibility that NO may in turn modulate the activity
of protein kinases.
Evidence indicates that the endothelial isoform of NOS can be myristylated
(Pollock et al 1992). Co- or posttranslational modification of proteins 
myristylation is thought to confer membrane association. Whereas the
macrophage and brain forms of NOS appear to be located primarily in soluble
fractions, the endothelial form of NOS is located predominantly in particulate
fractions (Forstermann et al 1991). None of the cloned NOS isoforms appear
to have hydrophobic signal sequences that would correspond to membrane-
associated regions. However, at the amino terminal portion, the endothelial
NOS contains a consensus sequence for N-myristyl transferase, an enzyme
that catalyzes myristylation (Kaplan et al 1988). The brain and macrophage
forms of NOS lack this consensus sequence (Bredt et al 1991c, Xie et al
1992). Incubation of bovine endothelial cells with [3I-t] myristate results in
the incorporation of myristate into the endothelial NOS (Pollock et al 1992).
Thus, the fatty acid acylation of the endothelial NOS may serve as a membrane
anchor. Site-directed mutagenesis of the N-myristyl transferase consensus
sequence is needed to determine whether this type of modification is required
for the localization of endothelial NOS to particulate fractions. Since there
are a few reports (Forstermann et al 1992, Hiki et al 1992) of insoluble forms
of both the macrophage and brain NOS enzymes, it will be interesting to see
whether myristylation may also target other forms of NOS to the membrane.
NO Donors, Scavengers and Inhibitors
A variety of pharmacological tools have been used to elucidate the functions
of NO. Many of the classic nitrovasodilators exert their actions by releasing
NO. These types of compounds, including sodium nitroprusside, hydroxyl-
amine, isosorbide dinitrate, 3-morpholino-sydnonimine (SIN-I), and S-ni-
troso-N-penicillamine (SNAP) can been used to assess the sufficiency of 
as a signaling molecule in various systems. These agents release NO by
different mechanisms: some compounds that are presumably membrane
impermeant, such as SIN-1 and SNAP, release NO in the extrasynaptic space;
others, such as hydroxylamine and isosorbide dinitrate, are thought to release
NO from intracellular locations, since they likely require cellular enzymes
such as catalases and cytochromes to release NO. It is important to note that
higher concentrations of NO donors may be .needed when working with intact
tissue (e.g. brain slices), since it has been shown that the concentrations 
donors required to elevate cGMP in slices are orders of magnitude higher than
those required to stimulate guanylyl cyclase in broken cell preparations
(Southam & Garthwaite 1991). This observation indicates that intact tissue
may possess mechanisms for rapidly inactivating NO.
In addition, several competitive inhibitors of the NOS are available,
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160 SCHUMAN & MADISON
including L-arginine derivatives such as NG-monomethyl-L-arginine (L-
NMMA, L-Me-Arg), NG-nitro-L-arginine (NARG), and L-nitro arginine
methyl ester (L-NAME). Many of these compounds also have D-isomeric
forms that do not inhibit NOS and thus serve as useful controls. Another
compound that has proven to be particularly useful in blocking NO’s action
is hemoglobin. NO and other putative messengers, such as carbon monoxide
(CO), bind avidly to the iron in the heme group of hemoglobin. Because
hemoglobin is a large protein, it is unlikely to cross cellular membranes. Thus,
when applied extracellularly hemoglobin may provide information regarding
NO’s function as an intercellular, rather than intracellular, messenger.
NO Effectors
The major effector of NO identified in many tissues is a soluble guanylyl
cyclase (Arnold et al 1977, Miki et al 1977, Murad et al 1978). The soluble
guanylyl cyclase is a heterodimer that contains a heme, the region responsible
for NO activation of the cyclase. When NO binds to Fe2+ in the porphyrin
ring of heme, this interaction pulls the Fe2+ out of the plane of the porphyrin
ring, resulting in a conformational change and activation of the guanylyl
cyclase (Wolin et al 1982). The resulting rises in cGMP levels can then affect
ion channel or phosphodiesterase activity, or activate a cGMP-dependent
protein kinase. In smooth muscle cells, the NO-induced rises in cGMP may
activate a cGMP-dependent protein kinase that is ultimately responsible for
muscle relaxation (Rapoport et al 1983). Alternatively, cGMP has been
observed to decrease intracellular Ca2+ levels, which may also contribute to
relaxation (Rashatwar et al 1987). Carbon monoxide, also recently identified
as a potential messenger molecule (Verma et al 1993), also activates guanylyl
cyclase (Brune & Ullrich 1987), although much less potently than 
(Furchgott & Jothianandan 1991).
NO can also combine with superoxide anions to form peroxynitrite.
Peroxynitrite ultimately decomposes to hydroxide and NO2 free radicals,
which are believed to be the bactericidal and tumoricidal effectors of activated
macrophages and neutrophils (Beckman et al 1990). NO may also exert its
cytotoxic effects by binding to the iron-sulphur centers of enzymes involved
in mitochondrial transport electron chain (Granger et al 1980), the citric acid
cycle (Drapier & Hibbs 1986), and DNA synthesis (Nakaki et al 1990). 
the inducible NOS exists in noncultured astrocytes, then the NO generated
by the inducible NOS may also contribute to the neuronal damage associated
with cerebral ischemia (Nowicki et al 1991).
NO may also produce its effects by stimulating the ADP-ribosylation of
proteins (Brune & Lapetina 1989). ADP-ribosylation involves the covalent
attachment of ADP-ribose to substrate proteins; this reaction is usually
catalyzed by cellular ADP-ribosyltransferases. Brune & Lapetina (1989)
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NO AND SYNAPTIC FUNCTION 161
demonstrated that sodium nitroprusside induced the ADP-ribosylation of a
39-kD protein in platelets. Later studies have identified this 39-kD protein as
glyceraldehyde 3’ phosphate dehydrogenase (GAPDH) (Dimmeler & Brune
1992, Kots et al 1992, Zhang & Snyder 1992) and have indicated that NO
promotes the auto-ADP-ribosylation of GAPDH, rather than activating a
distinct ADP-ribosyltransferase. NO first stimulates the S-nitrosylation of a
cysteine residue adjacent to the NAD-binding site in the catalytic region of
GAPDH (Molina y Vedia et al 1992). The subsequent auto-ADP-ribosylation
of GAPDH is thought to occur on this S-nitrosylated cysteine residue
(Dimmeler & Brune 1992, Zhang & Snyder 1992). The ADP-ribosylation 
GAPDH results in a reduction of the normal dehydrogenase activity of
GAPDH (Dimmeler et al 1992, Zhang & Snyder 1992). However, in addition
to stimulating auto-ADP-ribosylation of GAPDH, NO apparently may also
modulate the activity of endogenous cellular ADP-ribosyltransferases. Several
groups have also described NO-stimulated ADP-ribosylation of distinct
neuronal proteins (Williams et al 1992) that lack NAD+-binding domains,
including transducin (Ehret-Hilberer et al 1992) and other putative GTP-bind-
ing proteins (Duman et al 1991). The ADP-ribosylation of these proteins has
been proposed to be mediated by a distinct ADP-ribosyltransferase. Thus, it
appears that NO may stimulate both auto- and ADP-ribosyltransferase-medi-
ated covalent modifications. Future studies should be aimed at identifying
additional substrates for NO-stimulated ADP-ribosylation as well as deline-
ating the functional consequences of this form of covalent modification in
neurons.
NO AND SYNAPTIC FUNCTION
N-methyl-D-aspartate Receptor-Channel
One role of NO in the brain may be as a neuromodulatory substance, analogous
to some neurotransmitters. One example of NO’s modulatory function may
be it’s reported ability to influence ion currents through the N-methyl-D-as-
partate (NMDA) receptor channels. The NMDA receptor-channels are a rather
unique class of glutamate receptor channels that usually require depolarization
(Mayer & Westbrook 1987, Nowak et al 1984) to flux 2÷ (MacDermott et
al 1986, Jahr & Stevens 1987, Ascher & Nowak 1988). Thus, by modulating
current flow through this particular channel, NO could potentially influence
many Ca2÷-regulated neuronal processes that utilize this receptor, such as
synaptic transmission, plasticity, neurotoxicity, and some aspects of develop-
ment.
Several different NO-donating compounds ( odium nitroprusside, nitroglyc-
erin, S-nitrosocysteine, and SIN-l) have been shown to reduce NMDA
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162 SCHUMAN & MADISON
currents (Lei et al 1992, Manzoni et al 1992a). The use of several different
NO donors is important, since it has been shown that sodium nitroprusside
can exert effects on NMDA currents that can be reversed by hemoglobin, but
are apparently unrelated to NO since these effects are not shared by other
NO-donating compounds (East et al 1991, Manzoni et al 1992b). Manzoni 
al (1992a) demonstrated that the SIN-l-induced reduction in the NMDA
current was accompanied by an attenuation of NMDA-mediated rises in
intracellular Ca2÷, as revealed by measurements of Fura-2 fluorescence (see
also Hoyt et al 1992). The effects of NO could be blunted by simultaneous
application of hemoglobin, and were absent when NO-depleted SIN-1 was
applied. On the basis of these results, it was suggested that NO may play a
role as a feedback modulator. According to this scheme, when the NMDA
receptor is activated the resulting entry of Ca2+ into the cell activates the NO
synthase, leading to the reduction of subsequent NMDA currents.
Much has been learned about the possible mechanisms of the observed NO
modulation of NMDA currents. Early studies had shown that NMDA currents
could be influenced by the redox state of a site on the receptor channel complex
(Aizenman et al 1989, 1990; Lazarewicz et al 1989). A pair of closely-spaced
cysteine residues thought to reside on the extracellular side of the channel
may form a disulfide bond that constitutes the redox site of the NMDA
complex. Reducing this site with agents such as dithiothreitol (DTT) increases
the current flow through the channel, whereas oxidizing the redox site, by
using 5,5-dithio-bis-2-nitrobenzoic acid (DNTB), decreases the current flow
(Lei et al 1992). DNTB can reverse the DTT-induced potentiation of current
flow, but this reversal can be prevented by treatment with the irreversible
sulfhydryl alkylating agent N-ethylmalemide (NEM). Such treatments simi-
larly affect the synaptic currents through the NMDA channels (Tauck 1992).
The effect of NO on NMDA currents appears to be mediated through this
redox site. It has been proposed that the free sulfhydryl groups on the NMDA
channel complex are oxidized in the presence of NO to form S-nitrosothiols
(Lei et al 1992). In support of this idea, after treatment with NO-donating
compounds the oxidant DNTB had no further significant effect (Lei et al
1992). The reducing agent DTT could substantially reverse the effects of NO.
In addition, the action of nitrogylcerine was blocked by treatment with NEM.
Cyclic GMP apparently does not mediate the effect of NO at the redox site,
as application of cGMP did not have any effect on the current (East et al
1991, Kiedrowski et al 1992). Indeed, the SIN-l-induced decrease in the
NMDA current can still be recorded in isolated outside-out patches of
membrane, suggesting that NO’s effect is not mediated by a soluble
messenger.
Reduction of NMDA currents by NO may have significance for many
cellular processes involving the NMDA receptor. However, at present this
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NO AND SYNAPT1C FUNCTION 163
inhibition appears to be essentially a feedback mechanism, since the NMDA
receptor must first be activated (to flux Ca2+ that activates the NO synthase)
before the currents can be reduced. In light of this consideration, some
processes--those that depend on very brief activation of the NMDA recep-
tor-may not be affected by the subsequent inhibition of the NMDA current.
An example of such a process may be long-term potentiation (see below), 
which NMDA receptors are transiently activated during the induction of LTP,
but are not required for the maintenance or expression of LTP. Thus, this
feedback inhibitory mechanism may be of more relevance to processes that
involve prolonged activation of NMDA receptors, such as neurotoxicities.
Neurotoxicity
Considerable controversy surrounds the role of NO in various forms of
neurotoxicity that possess different etiologies. One possible consequence of
the NO-mediated reduction in NMDA currents discussed above could be
attenuation of NMDA-mediated neurotoxicity. In addition, it has been known
for some time that neurons that stain positive for NADPH diaphorase (and
thus presumably contain NOS) are particularly resistant to neurological insults
(Ferrante et al 1985, Beal et al 1986, Koh et al 1986, Hyman et al 1992).
Conversely, the documented participation of NO in macrophage-mediated cell
killing (Hibbs et al 1988) suggests that NO might be involved in promoting
glutamate-mediated cell death. The data examining NO’s role in glutamate-
induced toxicity often lead to different conclusions; some results are consistent
with NO acting as a neuroprotective agent while others suggest that NO is
neurotoxic.
Dawson et al (1991b) have shown that inhibition of NO production can
have profound effects in preventing glutamate and NMDA-mediated death of
cultured cortical neurons. Using a trypan blue exclusion assay, they demon-
strated that the application of NOS inhibitors attenuated the neurotoxic effects
of glutamate. This inhibition of toxicity could largely be reversed by the
application of excess L-arginine. In agreement, Izumi et al (1992) have shown
that in hippocampal slices NOS inhibitors can prevent glutamate and NMDA-
mediated cell death. As in the culture system, this inhibition is reversed by
the addition of excess L-arginine. These results suggest that NO promotes
and is necessary for glutamate-mediated cell death.
In contrast to the above results, other data show that NO can prevent
NMDA-mediated cell death. Lei et al (1992) have shown that application 
sodium nitroprusside or nitroglycerine prevents the toxicity of NMDA in
cultured cortical neurons. This study showed a parallel reduction in the NMDA
current, as well as diminished intracellular Ca2+ levels with NO. These
changes were proposed to underlie the observed protective effect of NO against
the NMDA-mediated toxicity.
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164 SCHUMAN & MADISON
Many studies examining the relationship between NO and glutamate/
I’!MDA-mediated toxicity have failed to support any role for NO, either
protective or toxic. Kiedrowski et al (1991) showed that sodium nitroprusside
could prevent toxicity, as in Lei et al (1992). However, it was concluded that
the protective effect of sodium nitroprusside was not mediated by NO, since
it was not reproduced by another NO donor, SNAP, but could be reproduced
by ferricyanide (a ferricyanide group is present in sodium nitroprusside). 
should be noted, however, that the results of Lei et al (1992) did not rely
entirely upon the use of sodium nitroprusside, but were also obtained with
another NO donor, nitroglycerine. In addition, in rats chronically treated with
NOS inhibitors, no decrease in NMDA toxicity could be detected (Lerner-
Natoli et al 1992). In other studies NOS inhibitors did not decrease the toxicity
caused by glutamate, NMDA, or other agonists in cultures of cerebellar
granule cells (Puttfarcken et al 1992), in neurons cultured from whole rat
brain (Demerle-Pallardy et al 1991), or in glial free neuronal cultures (Pauwels
& Leysen 1992).
Thus, experimental results support a role for NO in neurotoxicity ranging
from protective to no role to toxic. The discrepancies between these studies
could potentially arise from several different sources. First, they may simply
represent the outcomes of nonstandardization of technique and preparation.
Different cell populations may be differentially sensitive to NO. In addition,
differing ratios of cell types (neuronal vs glial) in different preparations may
contribute to the discrepancies. Also, the methods and durations of applica-
tions of NO donors and NOS inhibitors may also be important. Second, there
may be multiple pathways that mediate glutamate-induced toxicity. NO may
participate in neurotoxicity, but neurodegeneration could still proceed in the
absence of NO via a parallel redundant mechanism. Third, NO itself may
exert multiple, perhaps opposing actions, depending on the timing or
concentration of its application. A more precise definition of the role of NO
in cytotoxicity mediated by glutamate or other factors awaits further experi-
ments that consider the above issues. One result that does emerge clearly at
this time is that cGMP production stimulated by NO does not appear to play
any role in producing toxicity, since direct application of cGMP is not toxic
to cells (see Lustig et al 1992).
Secretion
In several different brain regions NO has been shown to modulate synaptic
function by altering the release of neurotransmitter from presynaptic nerve
endings. Using a push-pull cannula, Prast and Phillipu (1992) examined the
ability of the NO donor SIN-1 to modulate the basal release of acetylcholine
in the basal forebrain, an area where NOS-containing neurons are colocalized
with choline acetyltransferase (Dawson et al 1991a). Introduction of the 
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donor SIN- 1 into the superfusate induced a near doubling of the basal release
of acetylcholine. Superfusion of the tissue with the NOS inhibitor NARG
reduced the basal release of acetylcholine by roughly 40%, suggesting that
there is continuous NO production that regulates secretion in this system. In
hippocampal slices, the NO donor hydroxylamine stimulated the efflux of
[3HI norepinephrine and [14C] acetylcholine (Lonart et al 1992). The hydrox-
ylamine-stimulated release was attenuated by hemoglobin, suggesting that the
effect was mediated by NO. Extracellularly applied EGTA also abolished the
NO-stimulated release, suggesting that NO exerts its effect by modulating
Ca2+-dependent exocytosis.
Two groups have examined the effects of NO on both the basal and evoked
release of dopamine from rat striatal slices. Zhu & Luo (1992) observed that
basal dopamine release increased up to 330% of baseline following the
addition of sodium ni~roprusside. L-arginine also produced a large enhance-
ment of basal release when added to the bathing medium; this potentiation of
release could be blocked by the coadministration of the NOS inhibitor
L-Me-Arg. Hanbauer et al (1992) have reported an NMDA-evoked release 
[3HI dopamine that is sensitive to NOS inhibitors and hemoglobin. Exogenous
application of NO also elicited increases in the basal release of [3H] dopamine
from primary cultures of ventral mesencephalic neurons.
In addition to several examples of NO-induced stimulation of release, in
at least one system NO has also been shown to have an inhibitory influence
on secretion. The magnocellular secretory neurons of the paraventricular and
supraoptic nuclei in the hypothalamus tain intensely with antibodies to NOS
(Bredt et al 1990). The paraventricular nucleus is the major source of the
hypophysiotropic factor corticotropin-releasing hormone (CRH) (Kawano 
al 1988). L-arginine, NO donors, or NOS inhibitors had no effect on the basal
secretion of CRH in hypothalamic explants, as measured by radioimmunoas-
say (Costa et al 1993). However, the release of CRH induced by depolarization
(40 mM +) or t he cytokine i nterleukin 1 B was p otently r educed by e ither
L-arginine or an NO donor. The inhibitory effect of L-arginine was blocked
when the NOS inhibitor L-Me-Arg or hemoglobin was coincidently applied.
These results suggest that NOS activation upon depolarization may function
as inhibitory feedback contributing to hypotension by reducing CRH release.
Thus there are several examples of NO modulating the release of a variety
of secretory substances. It appears that in different systems NO is capable of
either increasing or decreasing neurotransmitter release. In theory, this
bipotential control could be accomplished by NO’s acting on different
downstream enzymes or secretory targets, or by a common target molecule
or enzyme whose modulation state determines whether release will be
augmented or depressed. As such, it will be interesting to examine the
molecular mechanisms by which NO modulates neurotransmitter release.
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166 SCHUMAN & MADISON
Because previous studies have shown that NO can modulate Ca2+ influx (Lei
et al 1992), it is possible that NO alters presynaptic Ca2+ influx or
homeostasis. Alternatively, NO may alter the function of various synaptic
vesicle proteins implicated in secretion.
Long-Term Potentiation
Long-term potentiation (LTP), which has been observed in many brain areas,
has proven to be a powerful system for the study of the molecular mechanisms
that underlie activity-dependent enhancement of synaptic strength. At the
CA1-Schaffer collateral synapses of the hippocampus, LTP occurs when the
excitatory synapses are stimulated such that the depolarization of postsynaptic
CA1 neurons is coincident with the release of neurotransmitter from the
presynaptic CA3 nerve terminals. This is usually accomplished through the
delivery of high-frequency stimulation to presynaptic axons (100 Hz; tetanus)
or through the pairing of postsynaptic depolarization ,produced by current
injection with low-frequency stimulation Of presynaptic axons (pairing). Most
of our understanding of the molecular Processes responsible for LTP has to
do with those events that underlie the initiation, or induction, of LTP. Studies
from several laboratories have highlighted a cascade of postsynaptic events
that initiate LTP, including postsynaptic depolarization (Malinow & Miller
1986), glutamate binding to the NMDA receptor-channel (Collingridge et 
1983), and Ca2+ influx (Lynch et al 1983, Malenka et al 1988). The rise 
Ca2+ has been proposed to activate any one or combination of postsynaptically
located Ca2+-dependent enzymes, including protein kinase C (Lovinger et al
1987; Malinow et al 1988, 1989), Ca2+/calmodulin-dependent protein kinase
II (Malenka et al 1989, Malinow et al 1989, Silva et al 1992), calpain (Lynch
& Baudry 1984), phospholipase A2 (Williams et al 1989), and NOS (Bohme
et al 1991, O’Dell et al 1991, Schuman & Madison 1991a, Haley et al 1992),
all of which have been implicated in LTP to some extent.
In contrast to the possible exclusive role of the postsynaptic neuron in the
induction of LTP, several lines of evidence suggest that the presynaptic neuron
may also participate in the longer lasting aspects of LTP, known as
maintenance and expression. Quantal analyses of synaptic transmission before
and after LTP have often concluded that at least part of the increase in synaptic
strength observed following LTP induction results from an increase in the
release of neurotransmitter (Bekkers & Stevens 1990, Malinow 1991,
Malinow & Tsien 1990, Kullman & Nicoll 1992, Malgaroli & Tsien 1992;
but see Foster & McNaughton 1991, Manabe t al 1992). Thus, LTP is induced
postsynaptically but may be expressed, at least in part, presynaptically. This
shift of locus requires that the presynaptic cell receive a. signal from the
postsynaptic cell that indicates that LTP induction is occurring. This postsyn-
aptically generated retrograde signal would then be responsible for bringing
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about increases in neurotransmitter release. An early candidate for this signal
was arachidonic acid, generated by a CaZ+-sensitive phospholipase
Extracellularly applied inhibitors of PLA2 have been shown to block LTP
(Williams et al 1989), and extracellular application of arachidonic acid
coupled with weak tetanic stimulation can enhance synaptic transmission
(Williams et al 1989), although the onset of this enhancement is much slower
than the onset of LTP.
More recently, several labs have queried the possibility that NO may
function as retrograde signal in LTP. Given the Ca2+- and calmodulin-depen-
dence of the brain NOS and the established role of both of these molecules
in LTP induction (Madison et al 1991), NO appears at the outset to 
particularly well suited to perform the functions of a retrograde signal. In
initial experiments we (Schuman & Madison 1991a) and others (Bohme et 
1991, O’Dell et al 1991, Haley et al 1992) showed that extracellular
application of NOS inhibitors prevents tetanus-induced LTP. The inhibition
of LTP produced by competitive NOS inhibitors can be reversed by the
addition of L-arginine, as would be expected if the actions of the inhibitors
are on the NOS. It appears that NO production is necessary only during LTP
induction, since NOS inhibitors applied 20-30 min after high-frequency
stimulation do not reverse established LTP (O’Dell et al 1991, Haley et al
1992).
The above experiments utilized extracellular bath application of NOS
inhibitors to demonstrate NO’s importance in the production of LTP.
However, these experiments do not indicate the synaptic site of NO genera-
tion. By definition, the retrograde signal must be produced in the postsynaptic
neuron. Indeed, this appears to be the case for NO, since NOS inhibitors
injected into the postsynaptic neuron will block LTP induced by pairing
postsynaptic depolarization with low frequency stimulation of afferents
(O’Dell et al 1991, Schuman & Madison 1991). Injection of the D-isomers
of NOS inhibitors has no effect on LTP production. Hemoglobin applied
extracellularly also attenuates LTP (Bohme t al 1991, O’Dell et al 1991,
Schuman & Madison 1991, Haley et al 1992), whereas methemoglobin, which
has a much lower affinity for NO, has no effect. The reduction of LTP by
hemoglobin is consistent with the idea that NO functions as an intercellular
signal, traveling from the post- to the presynaptic neuron.
If postsynaptically released NO interacts with the presynaptic terminal to
bring about LTP, then the exogenous application of NO coupled with
presynaptic activity should be sufficient to induce synaptic potentiation. The
ability of NO or NO donors to increase synaptic strength in hippocampal slices
has not been readily observed, possibly because of the extreme lability of NO
and the difficulty of reaching appropriate concentrations in the depth of the
tissue (Southam & Garthwaite 1991). However, a few groups have had some
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168 SCHUMAN & MADISON
success. Bohme and colleagues (Bohme et al 1991, Bon et al 1992) have
shown that extracellular application of two different NO donors, hydroxyl-
amine and sodium nitroprusside, can potentiate synaptic transmission in a
manner that occludes normal synaptically-induced LTP. Direct application of
NO has also been demonstrated to augment synaptic transmission: in cultured
hippocampal neurons NO increases the frequency of spontaneous miniature
synaptic events (O’Dell et al 1991). In hippocampal slices bathed in the
NMDA receptor antagonist AP5, NO induces potentiation when paired with
a weak tetanus (50 Hz), but not when it is applied in the absence of presynaptic
activity (Zhou et al 1993). One caveat regarding this study concerns the
relatively high frequency of presynaptic stimulation required to elicit the
NO-induced potentiation; in theory, frequencies as low as 1 Hz should be
sufficient to produce potentiation, given that this frequency of presynaptic
stimulation can induce LTP when paired with postsynaptic depolarization.
Nonetheless, the observed activity-dependence of the NO-induced potentiation
is noteworthy, since it may provide an explanation for how NO can mediate
the input-specific nature of LTP: only those synapses that are active during
LTP induction become potentiated (Barrionuevo & Brown 1983).
The existence of a diffusible retrograde signal in LTP raises interesting
possibilities regarding the specific synapses that will be influenced by its
generation. In the absence of a precise targeting mechanism or an extremely
efficient breakdown pathway, it is possible that a diffusible signal, such as
NO, will interact with nearby synapses that have not participated directly in
its production, resulting in a non-Hebbian heterosynaptic potentiation. Indeed,
Bonhoeffer and colleagues have observed this type of potentiation in cultured
hippocampal slices (Bonhoeffer et al 1989) and visual cortex slice s (Kossel
et al 1990). In these studies, pairing postsynaptic depolarization of an
individual neuron with low-frequency stimulation resulted in a decrease in
spike latency in the paired cell as well as a nearby cell. We (Schuman 
Madison 1991b, 1993) have also observed that in acute hippocampal slices,
LTP induced by pairing in one CA1 pyramidal can spread to nearby (~ 100
txm), but not spatially remote (> 500 txm) synapses. These results 
consistent with the postsynaptic generation of a diffusible factor, such as NO,
that spreads to influence nearby synapses.
How does NO bring about the increase in synaptic strength that underlies
LTP? An early study suggested that NO may activate a guanylyl cyclase,
since membrane permeant analogues of cGMP (coapplied with an NOS
inhibitor) partially reversed the inhibition of LTP normally observed with
NOS inhibitors (Haley et al 1992). Sweatt and colleagues have also observed
that tetanic stimulation results in large rises in cGMP that are blocked by NOS
inhibitors (Chetkovich et al 1993). However, if guanylyl cyclase is the target
of NO, then application of membrane permeant analogues of cGMP in
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conjunction with low-frequency presynaptic stimulation should be sufficient
to potentiate synaptic transmission. This is not what has been experimentally
observed (Schuman et al 1992). Under most stimulation parameters, extra-
cellular application of cGMP analogues has no effect on baseline levels of
synaptic transmission (Haley et al 1992). High-frequency stimulation deliv-
ered in the presence of cGMP analogues (and an NMDA receptor antagonist)
usually results in a transient depression (Schuman et al 1992). Additionally,
cGMP depresses a Ca2+ current in hippocampal neurons (Doenler & Alger
1988); at first glance, this result is the opposite of what might be expected if
cGMP were involved in increasing neurotransmitter release.
Another potentially interesting NO target in LTP may be a cytosolic
ADP-ribosyltransferase (ADPRT) (Brune & Lapetina 1989; Figure 2), 
earlier study (Gob & Pennefather 1989) showed that slices from rats pretreated
with pertussis toxin, a bacterial ADP-ribosyltransferase, failed to exhibit LTP.
Recent preliminary results suggest that LTP can be prevented by extracellular
application of ADP-ribosyltransferase inhibitors (Schuman et al 1992).
Postsynaptic injections of an ADPRT inhibitor did not prevent LTP, consistent
with a presynaptic requirement for ADPRT activity. However, the link
between NO production and ADP-ribosyltransferase activity in LTP is still
untested. It will be interesting to see if NO-induced increases in synaptic
strength are mediated by ADP-ribosyltransferase activity. Also, it remains to
be determined whether LTP-inducing high-frequency stimulation results in
the NO-dependent ADP-ribosylation of specific proteins.
In sum, evidence from several laboratories supports a role for NO as a
signaling molecule in LTP. However, the involvement of NO in LTP is not
without its mysteries or disputes. As mentioned previously, one caveat is the
failure of most histological studies to detect NOS in the CA1 pyramidal cell
region of the hippocampus. Recent studies, however, have identified NOS-
immunopositive (Schweizer et al 1993) and NADPH diaphorase-staining
(Wallace & Fredens 1992) CA1 pyramidal neurons. Also, since only one
brain NOS isoform has been identified thus far (Bredt et al 1991c), it 
possible that additional, as yet unidentified isoforms, not recognized by the
available antibodies or oligonucleotides, may also be present in these neurons.
Another area of controversy concerns reports of NOS inhibitor-insensitive
forms of LTP that occur under certain stimulation parameters (Gribkoff et al
1992, Chetkovich et al 1993) or at higher temperatures (Li et al 1992,
Chetkovich et al 1993). A recent study (Haley et al 1993) has examined both
of ttaese issues. These investigators found that at temperatures above 30°C,
NOS inhibitors block LTP induced by short (2 × 100 Hz for 0.25 s), but not
long (2 × 100 Hz for 0.5 s) duration tetanic stimulation. These results suggest
that at physiological temperatures stronger stimulation parameters may
activate alternative biochemical pathways (see also Chetkovich et al 1993).
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NOS inhibitors have also been reported to block NMDAomediated inhibition
of LTP (Izumi et al 1992). Taken together, these findings suggest previously
unappreciated complexities in the interactions between NO and the experi-
mental paradigms used in LTP studies. Thus, in future endeavors, much more
attention should be paid to the various LTP induction procedures and
experimental conditions that are used in different labs. The breadth of
biochemical pathways implicated in LTP is ever expanding. The task of future
experiments will be to understand how various putative signaling pathways
(e.g. arachidonic acid, carbon monoxide, and nitric oxide) may interact 
ultimately orchestrate the observed increases in synaptic strength. In addition,
the possibility that given biochemical pathways may be selectively invoked
based on the stimulation parameters used to induce LTP (Gribkoff et al 1992,
Haley et al 1993) or the preexisting history of the synapse (Izumi et al 1992,
Larkman et al 1992) needs to be explored further.
Long-Term Depression
Certain patterns of neuronal activity can also lead to persistent decreases in
synaptic strength, or long-term depression (LTD). Like LTP, LTD has been
documented in many brain areas, including visual cortex, the hippocampus,
and the cerebellum (Ito 1989). In the cerebellar cortex, the Purkinje cells
possess two separate sets of excitatory synapses, one from the parallel fibers
(granule cells axons) and one from the climbing fibers (inferior olive axons).
Both the parallel fiber and the climbing fiber synapses use glutamate as a
neurotransmitter. Conjunctive stimulation (1-4 I-Iz, for 25 s to 10 min) of the
parallel fibers and the climbing fibers produces a long-lasting depression of
synaptic transmission at the synapses between the parallel fibers and Purkinje
cells. The observed decrease in synaptic strength results from a reduction in
the sensitivity of postsynaptic AMPA receptors (ito et al 1982, Crepel 
Krnpa 1988, Hirano 1991, Linden et al 1991).
Studies aimed at elucidating the molecular mechanisms that underlie LTD
have outlined a series of events that includes glutamate binding to postsynaptic
receptors, rises in intracellular Caz+, and activation of protein kinase(s).
Glutamate released from climbing fibers is thought to activate primarily the
AMPA class of receptor. Because each climbing fiber possesses multiple
synapses with each Purkinje cell, climbing fiber activity can potently
depolarize Purkinje neurons, resulting in the activation of voltage-dependent
Ca2+ channels and the influx of Ca2+. The glutamate released from parallel
fibers has been proposed to activate both AMPA and metabotropic classes of
glutamate receptors. Activation of both of these receptors is a necessary step
in the induction of LTD, because antagonists to either class of receptor will
block LTD (Linden et al 1991). Activation of the metabotropic receptor
activates phospholipase C, resulting in generation of diacylglycerol and an
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172 SCHUMAN & MADISON
IP3-mediated rise in intracellular Ca2+. The Ca2+ signal (also derived from
climbing fiber-mediated activation of voltage-sensitive Ca2+ channels), as
well as the generation of diacylglycerol, serves to activate protein kinase C.
PKC activity is required for LTD (Linden & Connor 1991), and LTD can 
mimicked by the application of phorbol esters (Crepel & Krupa 1988). 
addition to PKC, activation of cGMP-dependent protein kinase has also been
implicated in LTD, as discussed in further detail below. The activity of these
protein kinases has then been proposed tO bring about alterations in the
sensitivity of AMPA-type glutamate receptors by directly phosphorylating
channel subunits or associated molecules.
Where might NO fit into the induction cascade outlined above? The brain
NO synthase that was originally purified from cerebellum (Bredt & Snyder
1990) is found in the granule cells as well as the inhibitory basket cells, but
has not been detected in the Purkinje cells (Bredt et al 1991b). Thus, the 2÷
signal in Purkinje cells that is required for LTD most likely does not function
as an activator of NOS (unless an as yet unidentified isoform of NOS exists
in Purkinje cells). However, NOS may be activated by an influx of Ca2÷ in
the granule cells or by granule cell-induced excitation of the basket cells
(Figure 2). If NO plays a role in LTD, then guanylyl cyclase is a likely target,
since cGMP concentrations are much higher in the cerebellum than in other
brain areas. Immunohistochemical studies indicate that guanylyl cyclase
(Nakane et al 1983) and cGMP-dependent protein kinase (Lohmann et 
1981) are present in Purkinje cell bodies, dendrites, and axons. In contrast,
cGMP is found primarily in Bergmann fibers and cell bodies, and in astroglial
cells in the granular layer and white matter, but appears to be absent from
Purkinje cells (de Vente et al 1989). In addition, several different agonists,
including glutamate and kainate, as well as the NO donor sodium nitropruss-
ide, fail to elevate cGMP in Purkinje neurons (Garthwaite & Garthwaite 1987).
These findings may indicate that the guanylyl cyclase present in Purkinje cells
is stimulated by an as yet unidentified signal transduction cascade.
Is there any direct evidence that NO participates in LTD? Crepel & Jaillard
(1990, Daniel et al 1993) demonstrated that extracellular application of the
NOS inhibitor L-NMMA blocks LTD produced by pairing parallel fiber-me-
diated EPSPs with postsynaptic Purkinje cell Ca2+ spikes in cerebellar slices.
However, LTD is not blocked when the NOS inhibitor is included in the
whole-cell recording pipette, suggesting that NO production is not required
in Purkinje cells (Daniel et al 1993). In contrast, inclusion of an NO donor
in the Purkinje cell recording pipette resulted in a progressive decline in the
amplitude of parallel fiber-mediated EPSPs (Daniel et al 1993). This NO-me-
diated decrease in the EPSP prevented the subsequent induction of LTD by
pairing parallel fiber stimulation with Ca2+ spikes. LTD can be prevented by
the extracellular application of methylene blue, which has been reported to
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NO AND SYNAPTIC FUNCTION 173
inhibit guanylyl cyclase (Crepel & Jaillard 1990). In addition, bath 
intracellular application of 8-bromo-cGMP also depressed the Purkinje cell
EPSP. These results are consistent with a role for NO in LTD in which NO
is produced by parallel fiber stimulation and then diffuses into the Purkinje
ceils to activate guanylyl cyclase and depress the EPSP.
A role for NO has been explored in another LTD paradigm. Ito & Karachot
(1990) have documented a quisqualate (QA)-induced desensitization 
Purkinje cell glutamate receptors in grease gap recordings from Purkinje cell
axons in cerebellar slices (Ito & Karachot 1989). QA is believed to induce
th6 observed desensitization by acting upon two classes of glutamate receptors,
both the ionotropic AMPA type and the metabotropic type. Application of
AMPA alone does not induce the desensitization (presumably because it does
not act at the metabotropic receptor), but the coapplication of AMPA and the
NO donor sodium nitroprusside or a membrane permeant cGMP analogue
will produce desensitization (Ito & Karachot 1990). Also, prior incubation
with either the NOS inhibitor L-NMMA or hemoglobin blocked the QA-in-
duced desensitization of responses. These results can be contrasted to the
findings of Linden & Connor (1992), who showed that in cultured Purkinje
neurons, NO is not important for the depression glutamate currents produced
by conjoint depolarization and glutamate iontophoresis. The differences in
these two findings may be accounted for by the different preparations
(cerebellar slices vs cultured Purkinje neurons) or the different induction
procedures (quisqualate applications vs glutamate iontophoresis coupled with
depolarization) used.
Another study has shown that a correlate of LTD, the alteration of
extracellular K÷ concentration ([K÷]o), is also influenced in a manner
consistent with a role for NO. When the parallel fibers are stimulated in the
molecular layer of a cerebellar slice, an increase in ([K÷]o) can be recorded
with an ion-sensitive electrode (Shibuki & Okada 1990). LTD, produced 
conjunctive stimulation, is accompanied by a depression of the parallel
fiber-elicited K÷ response (Shibuki & Okada 1990). The conjunctive stimu-
lation-induced decrease in ([K ÷ ]o) is blocked when cerebellar slices are bathed
in the NOS inhibitor L-NMMA or hemoglobin (Shibuki & Okada 1991). 
addition, sodium nitroprusside or a cGMP analogue paired with parallel fiber
stimulation significantly depressed the K+ response. This study also showed
that an NO-sensitive probe inserted in the molecular layer was able to detect
increases in NO concentration following conjunctive stimulation.
Thus, evidence from several studies suggests that NO functions as a
important signal in the cellular events that underlie LTD. How might NO be
incorporated into the anatomical and cellular circuitry important for LTD?
The most parsimonious transduction scheme would most likely begin with
NO generation in the basket or granule cells, induced by parallel fiber
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174 SCHUMAN & MADISON
stimulation (Figure 2). NO would then diffuse to Purkinje cells to activate
guanylyl cyclase, increase cGMP levels, and potentially activate a cGMP-de-
pendent protein kinase. A cGMP-dependent protein kinase is one kinase that
has been proposed to mediate the decreased postsynaptic responsiveness by
phosphorylating a postsynaptic AMPA receptor or associated molecule (Ito
1989). A caveat to the above sequence of events is that researchers have been
unable to observe NO stimulation of Purkinje cell guanylyl cyclase (Garth-
waite & Garthwaite 1987). In addition, the molecular underpinnings of the
proposed down-regulation of the AMPA channels need to be further explored.
It will be interesting to see whether the particular AMPA receptor subufiits
expressed in Purkinje cells possess consensus sites for phosphorylation by
cGMP protein kinase or PKC, and whether NO can stimulate the phosphor-
ylation of the receptor subunits by either of these kinases.
Animal Learning
The involvement of NO in LTP and LTD has prompted several investigators
to explore the role of NO in the acquisition and retention of learned behavioral
tasks, such as the Morris Water Maze, a radial arm maze, classical
conditioning of the eyeblink response, and passive avoidance learning. The
Morris Water Maze (Morris 1984) is a spatial learning task that requires 
animal to find a platform submerged in a pool of opaque water based on
spatial cues provided by the surrounding environment. During training trials,
animals are placed at random positions in the pool and the amount of time it
takes them to find the submerged platform is measured (escape latency).
Previous work has shown that the hippocampus (Morris et al 1990) and NMDA
receptor activity (Morris et al 1986) are required for animals to learn this task.
A recent study suggests that one target of the NMDA-mediated Ca2+ influx
that is necessary for learning this spatial task may be a NOS. Rats that received
systemic injections of an NOS inhibitor (L-NAME; 75 mg/kg) prior to training
had significantly longer escape latencies than control animals (Chapman et al
1992). The effect of the NOS inhibitor was abolished when L-arginine was
coadministered. When NOS inhibitors were injected after animals learned the
task, the animals retained their ability to navigate to the platform, implying
that NOS activity is required during the acquisition but not the retention of
the memory.
Bohme and colleagues (1993) have also implicated NO in another test 
spatial learning, performance in a radial arm maze. In this task, rats were
required to make one visit to each arm of an eight-arm radial maze, in order
to obtain a food reward. An error was recorded when a rat entered a previously
visited arm within a given training period. Vehicle-injected controls can
successfully navigate (< 2 errors/session) in the maze by the third day 
training. Rats that received injections of the NOS inhibitor L-NARG (100
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mg/kg, i.p.) for four days preceding the initiation of the training mastered
this task much more slowly than other animals. This study also showed that
the same injection of L-NARG prevented LTP in hippocampal slices prepared
ex vivo. Lower doses (25 mg/kg) that were ineffective in blocking LTP from
ex vivo slices also did not impair maze learning.
Classical conditioning of eyeblink responses involves pairing a tone
(conditioned stimulus) with an air puff to the eye (unconditioned stimulus),
which normally elicits an eyeblink. After days of training, the tone alone will
elicit an eyeblink (conditioned response). Lesion studies in rabbits indicate
that the acquisition of this learned behavior requires the cerebellum (McCor-
mick & Thompson 1984). Given the marked presence of the NOS in cerebellar
granule cells, NO seems at the outset to be a good candidate for a mediator
of this type of leaming. Indeed, the acquisition of this classically conditioned
response was blocked in rabbits that received daily injections (10 mg/kg) 
L-NAME prior to training (Chapman et al 1992). However, on subsequent
days when the injections were switched to D-NAME, the animals showed
normal acquisition of the conditioned response. Interestingly, animals that
had received D-NAME injections learned successfully, and their retention of
the conditioned response could not be attenuated by subsequent injections of
L-NAME. One caveat to the above study concems the inverse dose-response
relationship observed: lower doses (10 mg/kg) of L-NAME were effective 
preventing the conditioned response, whereas higher doses (75 mg/kg) were
ineffective.
Two studies have examined the requirement for NOS activity in different
passive avoidance learning tasks. In a chick one-trial passive avoidance
paradigm, chicks that initially peck at a bead coated with a bitter substance
subsequently avoid dry, uncoated beads. A previous study suggested that this
type of leaming has been shown to rely on activation of NMDA receptors
(Burchuladze & Rose 1990). Holscher & Rose (1992) found that chicks 
received i.p. injections of NARG prior to training exhibited an initial disgust
avoidance of the bitter bead, but did not avoid the bead during the test phase.
The initial display of avoidance towards the bitter bead suggests that the
NARG injections do not block learning by simply altering taste perception.
These investigators also noted a failure of NOS inhibitors to alter established
memory. In contrast, in a one-trial shock avoidance learning task, NOS
inhibitors appeared not to interfere with learning (Bohme t al 1993). In this
study, rats that received NOS inhibitor injections (100 mg/kg) leamed 
rapidly as control animals to avoid adark chamber where they had previously
experienced an electric shock. Thus, a requirement for NO in passive
avoidance learning appears to depend on the species or the particulars of the
experimental protocol, which may include the sensory modalities utilized
during the tasks. It may be the case that NO is important for learning tasks
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176 SCHUMAN & MADISON
that involve olfactory systems, since NOS inhibitors have also been shown
to be important for another form of olfactory memory (Bohme t al 1993).
Thus several studies suggest that NO may participate in the acquistion of
learned behaviors. However, a general caveat that must be applied to these
studies involves potential systemic effects of blocking NO production.
Alterations in blood pressure could alter an animal’s ability to learn for a variety
of reasons including alterations in motivation or activation of compensatory
physiological systems that oppose learning. In addition, with the modes of
inhibitor administration used in these studies (systemic or intaperitoneal
injections) it is impossible to ascertain the site, neural or peripheral, where the
inhibitor is action. A more informative approach might involve direct injections
of NOS inhibitors into brain structures previously implicated in the behavioral
changes. Nonetheless, keeping the above considerations in mind, these studies
make a promising start toward the elucidation of how NO may modulate
complex behavioral phenomena like learning and memory.
PERSPECTIVES
We have summarized data that suggests that NO is an important signaling
molecule in a variety of physiological and pathophysiological processes. The
observation that neuronal NOS requires both Ca2+ and calmodulin for its
activity raises the possibility that NO may function in many other systems
where rises in intracellular Ca2+, particularly those contributed by NMDA
receptors, are known to act as a triggering step. Thus, the examples of
NO-induced modulation discussed in this review are, no doubt, just a
beginning.
In the various behavioral and cellular models of plasticity where the role
of NO has been explored, it appears that NO functions as an early signal,
responsible for the acquisition of information rather than its maintenance or
long-term storage. This idea is suggested by the demonstrations that NOS
inhibitors are without effect when injected after animals have learned either
the Morris Water Maze, classical conditioning of eyeblink responses, or a
passive avoidance task. These observations nicely parallel the finding that
NOS inhibitors applied after the induction of LTP do not affect the enhanced
synaptic transmission. Thus, continuous production of NO does not appear
to underlie the long-lasting phases of synaptic or behavioral plasticity. Indeed,
short-lived production of NO is what might be expected, given what is known
about the activity of constitutive NOSs. However, it remains to be determined
whether the activity of constitutive NOSs can be modified to produce NO for
longer durations. In addition, it will be interesting to see if inducible NOSs,
which produce NO for prolonged periods of time, may also be present in the
central nervous system (see Galea et al 1992).
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Although it has not been explored in much detail, a role for NO appears
promising (Gally et al 1990, Montague et al 1991) in the development and
the stabilization of synaptic connections. Both neuronal activity and bidirec-
tional synaptic signaling have been proposed to underlie the remodeling and
refinement of many developing synapses (Kandel & O’Dell 1992, Goodman
& Shatz 1993). NO may be well-suited to mediate some of these functions,
since it is diffusible and optimally positioned to detect neural activity by virtue
of the Ca2+ -dependence of the NOS. In addition, NOS has also been localized
to neurons known to play an important role in development. For example, in
the cortex, NOS is localized to a small population of interneurons that are
dispersed through layers II-VI as well as in the subcortical white matter
(Mizukawa et al 1988). These interneurons in the subcortical white matter are
derived from the population of subplate neurons (Chun & Shatz 1989), which
are known to pioneer the development of cortical connections (Ghosh et al
1990).
The notion of diffusible gaseous messengers raises the problem of how
signaling specificity can be achieved. As mentioned above, one way speci-
ficity can be accomplished is to require the messenger production to coincide
with synaptic activity. Indeed, this is what has been observed experimentally
in the case of NO-induced increases in synaptic strength in the hippocampus
(Zhou et al 1993). This concept is also highlighted by a recent report
demonstrating NO-induced enhancement of immediate early gene expression
(Peunova & Enikolopov 1993). These investigators observed that NO can
substantially augment the CaZ+-induced increases in c-los expression, al-
though NO alone was without effect. The facilitatory effect of NO required
strict temporal contiguity of the Ca2+ and NO signals, indicating that
coincidence detection can occur at the level of transcriptional regulation.
Similar mechanisms to confer specificity may be employed in other systems
that utilize diffusible messengers. Achieving a molecular understanding of
NO’s interaction with synaptic activity is an important area of future
investigation.
Finally, although this review has dealt exclusively with potential functions
of NO, it appears that there may be other forms of small diffusible signaling
molecules, including CO (Verma et at 1993) and OH (Zoccarato et al 1989).
The diffusibility of these messengers allows for coordinated molecular
communication between ensembles of neurons, a feature not provided by
conventional neurotransmitters. In addition, the extent and duration of each
messenger’s influence can be controlled by the different half-lives of the
molecules as well as different diffusion constants. In future studies it will be
interesting to see how the enzymatic pathways that make these new messenger
molecules can be regulated and how these signals may ultimately interact to
modulate the activity of synapses.
www.annualreviews.org/aronline
Annual Reviews
A
nn
u.
 R
ev
. N
eu
ro
sc
i. 
19
94
.1
7:
15
3-
18
3.
 D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
178 SCHUMAN & MADISON
Literature Cited
Aizenman E, Lipton SA, Loring RH. 1989.
Selective modulation of NMDA responses
by reduction and oxidation. Neuron 2:1257-
63
Aizenman E, Hartnett KA, Reynolds IJ. 1990.
Oxygen free radicals regulate NMDA recep-
tor function via a redox modulatory site.
Neuron 5:841-46
Arnold WP, Mittal CK, Katsuki S, Murad F.
1977. Nitric oxide activates guanylate cy-
clase and increases guanosine 3’:5’-cyclic
monophosphate l vels in various tissue prep-
arations. Proc. Natl. Acad. Sci. USA 74:
3203-7
Ascher P, Nowak L. 1988. The role of divalent
cations in the N-methyl-D-aspartate re-
sponses of mouse central neurones in culture.
J. Physiol. (London) 399:247-66
B arrionuevo G, Brown TH. 1983. Associative
long-term potentiation in hippocampal
slices. Proc. Natl. Acad. Sci. USA 80:7347-
51
Beal MF, Kowall NW, Ellison DW, et al.
1986, Replication of the neurochemical char-
acteristics of Huntington’s disease by
quinolinic acid. Nature 321 : 168-71
Beckman JS, Beckman TW, Chen J, et al.
1990. Apparent hydroxyl radical production
by peroxynitrite: implications for endothelial
injury from nitric oxide and superoxide.
Proc. Natl. Acad. Sci. USA 87:1620-24
Bekkers JM, Stevens CF. 1990. Presynaptic
mechanism for long-term potentiation in the
hippocampus. Nature 346:724-29
Bohme GA, Bon C, Lemaire M, et al. 1993.
Altered synaptic plasticity and memory for-
mation in nitric oxide inhibitor treated rats.
Proc. Natl. Acad. Sci. USA In press
Bohme GA, B on C, Stutzmann JM, et al. 1991.
Possible involvement of nitric oxide in long-
term potentiation. Eur. J. Pharmacol. 199:
37%81
Bon C, Bohme GA, Doble A, et al. 1992. A
role for nitric oxide in long-term potentia-
tion. Eur. J. Neurosci. 4:420-24
Bonhoeffer T, Staiger V, Aertsen A. 1989.
Synaptic plasticity in the rat hippocampal
slice cultures: local "Hebbian" conjunction
or pre- and postsynaptic stimulation leads to
distributed synaptic enhancement. Proc.
Natl. Acad. Sci. USA 86:8113-17
Bredt DS, Ferris CD, Snyder SH. 1992. Nitric
oxide synthase regulatory sites: phosphory-
lation by cyclic AMP dependent protein
kinase, protein kinase C, calcium/calmo-
dulin protein kinase; identification of flavin
and calmodulin binding sites. J. Biol. Chem.
267:10976-81
Bredt DS, Glatt CE, Hwang PM, et al. 1991b.
Nitric oxide synthase protein and mRNA are
discretely localized in neuronal populations
of mammalian central nervous system to-
gether with NADPH diaphorase. Neuron
7:615-24
Bredt DS, Hwang PH, Glatt C, et al. 1991c.
Cloned and expressed nitric oxide synthase
structurally resembles cytochrome P-450 re-
ductase. Nature 351:71 4-18
Bredt DS, Hwang PH, Snyder SH. 1990.
Localization of nitric oxide synthase indicat-
ing a neural role for nitric oxide. Nature
347:768-70
Bredt DS, Snyder SH. 1990. Isolation of nitric
oxide synthetase, a calmodulin-requiring en-
zyme. Proc. Natl. Acad. Sci. USA 87:682-
85
Brune B, Lapetina EG. 1989. Activation of a
cytosolic ADP-ribosyltransferase by nitric
oxide generating agents. J. Biol. Chem.
264:8455-58
Brune B, Lapetina EG. 1990. Properties of a
novel nitric oxide-stimulated ADP-ribosyl-
transferase. Arch. Biochem. Biophys. 279:
286-90
Brune B, Lapetina EG. 1991. Phosphorylation
of nitric oxide synthase by protein kinase A.
Biochem. Biophys. Res. Commun. 181:921-
26
Brune B, Ullrich V. 1987. Inhibition of platelet
aggregation by carbon monoxide is mediated
by activation of guanylate cyclase. Mol.
Pharmacol. 32:497-504
Burchuladze R, Rose SPR. 1990. Memory
formation in the chick depends on membrane
bound protein kinase C. Brain Res. 535:131-
38
Chapman PF, Atkins CM, Allen MT, et al.
1992. Inhibition of nitric oxide synthesis
impairs two different forms of learning.
NeuroReport 3:567-70
Chetkovich DM, Klann E, Sweatt JD. 1993.
Nitric oxide synthase-independent long-term
potentiation in area CA1 of hippocampus.
NeuroReport 4:919-22
Chun JJM, Shatz CJ. 1989. The earliest gen-
erated neurons of the cat cerebral cortex:
characterization by MAP2 and neurotrans-
mitter immunohistochemistry during fetal
life. J. Comp. Neurol. 282:555-69
Collingridge GL, Kehl S J, McLennan H. 1983.
Excitatory amino acids in synaptic transmis-
sion in the Schaffer collateral-commisural
pathway of the rat hippocampus. J. Physiol.
334:33~-6
Costa A, Trainer P, Besser M, Grossman A.
1993. Nitric oxide modulates the release of
corticotropin-releasing hormone from rat hy-
pothalamus in vitro. Brain Res. 605:187-92
Crepel F, Jaillard D. 1990. Protein kinases,
nitric oxide, and long-term depression of
www.annualreviews.org/aronline
Annual Reviews
A
nn
u.
 R
ev
. N
eu
ro
sc
i. 
19
94
.1
7:
15
3-
18
3.
 D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
NO AND SYNAPTIC FUNCTION 179
synapses in the cerebellum. NeuroReport.
1:133-36
Crepel F, Krupa M. 1988. Activation of protein
kinase C induces a long-term depression of
glutamate sensitivity of cerebellar Purkinje
cells. An in vitro study. Brain Res. 458:397-
401
Daniel H, Hemart N, Jaillard D, Crepel F.
1993. Long-term depression requires nitric
oxide and guanosine 3’:5’ cyclic monophos-
phate production in cerebellar purkinje cells.
Eur. J. Neurosci. 5:1079-82
Dawson TM, Bredt DS, Fotuhi M, et al.
1991a. Nitric oxide synthase and neuronal
NADPH diaphorase are identical in brain
and peripheral tissues. Proc. Natl. Acad.
Sci. USA 88:7797-801
Dawson VL, Dawson TM, London ED, et al.
199 lb. Nitric oxide mediates glutamate neu-
rotoxicity in primary cortical culture. Proc.
Natl. Acad. Sci. USA 88:6368-71
Demerle-Pallardy C, Lonchampt M-O, Chab-
rier P-E, Braquet P. 1991. Absence of
implication of L-arginie/Nitric oxide path-
way on neuronal cell injury induced by
1-glutamate or hypoxia. Biochem. Biophys.
Res. Commun. 181:456-64
Desai KM, Sessa WC, Vane JR. 1991. In-
volvement of nitric oxide in the reflex relax-
ation of the stomach to accomodate food or
fluid. Nature 351:477-79
de Vente J, Bol JGJM, Steinbusch HWM.
1989. Localization of cGMP in the cerebel-
lum of the adult rat: an immunohistochemi-
cal study. Brain Res. 504:332-37
Dimmeler S, Brune B. 1992. Characterization
of a nitric oxide-catalyzed ADP-ribosylation
of glyceraldehyde-3-phosphate dehydroge-
nase. Eur. J. Biochem. 210:305-10
Dimmeler S, Lottspeich F, Brune B. 1992.
Nitric oxide causes ADP-ribosylation and
inhibition of glyceraldehyde-3-phosphate de-
hydrogenase. J. Biol. Chem. 267:16771-74
Doerner D, Alger BE. 1988. Cyclic GMP
depresses hippocampal Ca ~+ current through
a mechanism independent of cGMP-depen-
dent protein kinase. Neuron 1:693-99
Drapier JC, Hibbs JB. 1986. Murine cytotoxic
activated macrophages inhibit aconitase in
tumor cells. Inhibition involves the iron-sul-
fer prosthetic group and is reversible. J.
Clin. Invest. 78:790--97
Duman RS, Terwilliger RZ, Nestler EJ. 1991.
Endogenous ADP-ribosylation in brain: ini-
tial characterization of substrate proteins. J.
Neurochem. 57:2124-32
East SJ, Batchelor AM, Garthwaite J. 1991.
Selective blockade of N-methyl-D-asparate
receptor function by the nitric oxide donor,
nitroprusside. Eur. J. Pharma¢ol. 209:119-
21
Ehret-Hilberer S, Nullans G, Aunis D,
Virmaux N. 1992. Mono ADP-ribosylation
of transducin catalyzed by rod outer segment
extract. FEBS Lett. 309:394-98
Ferrante RJ, Kowall NW, Richardson EP, et
al. 1985. Selective sparing of a class of
striatal neurons in Huntington’s disease. Sci-
ence 230:561-63
Forstermann U, Schmidt HHHW, Kohlhass
KL, Murad F. 1992. Induced RAW 267.4
macrophages express soluble and particulate
nitric oxide synthase: inhibition by transfer-
ring growth factor-beta. Eur. J. Pharmacol.
225:161-65
Forstermann U, Pollock JS, Schmidt HHHW,
et al. 1991. Calmodulin-dependent endothe-
lium-derived relaxing factor/nitric oxide
synthase activity is present in the particulate
and cytosolic fractions of bovine aortic en-
dothelial cells. Proc. Natl. Acad. Sci. USA
88:1788-92
Foster TC, McNaughton BL, 1991. Long-term
enhancement of CA1 synaptic transmission
is due to increased quantal size, not quantal
content. Hippocampus 1:79-91
Furchgott RF, Jothianandan D. 1991. Endothe-
lium-dependent and independent vasodila-
tion involving cGMP: relaxation induced by
nitric oxide, carbon monoxide, and light.
Blood Vessels 28:52-61
Furchgott RF, Zawadski JV. 1980. The oblig-
atory role of endothelial cells in the relax-
ation of arterial smooth muscle by
acetylcholine. Nature 288:373-76
Galea E, Feinstein DL, Reis DJ. 1992. Induc-
tion of calcium-independent itric oxide syn-
thase in primary rat glial cultures. Proc.
Natl. Acad. Sci. USA 89:10945-49
Gaily JA, Montague PR, Reeke GN, Edelman
GM. 1990. The NO hypothesis: possible
effects of a short-lived, rapidly diffusible
signal in the development and function of
the nervous system. Proc. Natl. Acad. Sci.
USA 87:3547-51
Garthwaite J, Charles SL, Chess-Williams R.
1988. Endothelium-derived relaxing factor
release on activation of NMDA receptors
suggests role as intracellular messenger in
the brain. Nature 336:385-88
Garthwaite J, Garthwaite G. 1987. Cellular
origins of cGMP responses to excitatory
amino acid receptor agonists in rat cerebel-
lum in vitro. J. Neurochem. 48:29-39
Geller DA, Lowenstein C J, Shapiro RA, et al.
1993. Molecular cloning and expression of
inducible nitric oxide synthase from human
hepatocytes. Proc. Natl. Acad. Sci. USA
90:3491-95
Ghosh A, Antonini A, McConnell SK, Shatz
CJ. 1990. Requirement for subplate neurons
in the formation of thalamocortical connec-
tions. Nature 347:179-81
Goh JW, Pennefather PS. 1989. A pertussis
toxin-sensitive G protein in hippocampal
long-term potentiation. Science 244:980-83
www.annualreviews.org/aronline
Annual Reviews
A
nn
u.
 R
ev
. N
eu
ro
sc
i. 
19
94
.1
7:
15
3-
18
3.
 D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
180 SCHUMAN & MADISON
Goodman CS, Shatz CJ. 1993. Developmental
mechanisms that generate precise patterns of
neuronal connectivity. Neuron 10:77-98
Granger DL, Taintor RR, Cook JL, Hibbs
JB. 1980. Injury of neoplastic cells by
murine macrophages leads to inhibition
of mitochondrial respiration. J. Clin. Invest.
65:357-60
Gribkoff VK, Lum-Ragan JT. 1992. Evidence
for nitric oxide synthase inhibitor-sensitive
and insensitive hippocampal syuaptic poten-
tiation J. Neurophysiol. 68:639-42
Griffith TM, Edwards DH, Newby AC, et al.
1986. Production of endothelium-derived re-
laxant factor is dependent on oxidative phos-
phorylation and extracellular calcium.
Cardiovasc. Res. 20:7-12
Haley JE, Wilcox GL, Chapman PF. 1992. The
role of nitric oxide in long-term potentiation.
Neuron 8:211-16
Haley JE, Malen PL, Chapman PF. 1993.
Nitric oxide synthase inhibitors block LTP
induced by weak, but not strong, tetanic
stimulation at physiological brain tempera-
tures in rat hippoeampal slices. Neurosci.
Lett. In press
Hanbauer I, Wink D, Osawa Y, et al. 1992.
Role of nitric3oxide in NMDA-evoked re-
lease from [ H]-dopamine striatal slices.
NeuroReport 3:409-12
Hibbs JB, Vavrin Z, Taintor RR. 1987. L-ar-
ginine is required for expression of the
activated macrophage effector mechanism
causing selective metabolic inhibition in tar-
get cells. J. Immunol. 138:550-56
Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM.
1988. Nitric oxide: a cytotoxi¢ activated
macrophage effector molecule. Biochem.
Biophys. Res. Commun. 157:87-94
Hiki K, Hattori R, Kawai C, Yui Y. 1992.
Purification of insoluble nitric oxide syn-
thase from rat cerebellum. J. Biochem. 111:
556-58
Hirano T. 1991. Differential pre- and postsyn-
aptic mechanisms for synaptic potentiation
and depression between a granule cell and a
Purkinje cell in rat cerebellar culture. Syn-
apse 7:321-23
Holscher C, Rose SPR. 1992. An inhibitor of
nitric oxide synthesis prevents memory for-
mation in the chick. Neurosci. Len. 145:
165-67
Hope BT, Michael G J, Knigge KM, Vincent
SR. 1991. Neuronal NADPH diaphorase is
a nitric oxide synthase. Proc. Natl. Acad.
Sci. USA 88:2811-14
Hoyt KR, Tang L-H, Aizenman E, Reynolds
IJ. 1992. Nitric oxide modulates Nb’lDA-in-
e+duced increases in intracellular Ca in cul-
tured rat forebrain neurons. Brain Res. 592:
310-16
Hyman BT, Marzloff K, Wenniger JJ, et al.
1992. Relative sparing of nitric oxide syn-
thase-containing neurons in the hippocampal
formation in Alzheimer’s disease. Ann. Neu-
rol. 32:818-20
Ignarro LJ, Buga GM, Wood KS, et al. 1987.
Endothelium-derived relaxing factor pro-
duced and released from artery and vein is
nitric oxide. Proc. Natl. Acad. Sci. USA
84:9265-69
lto M. 1989. Long-term depression. Annu.
Rev. Neurosci. 12:85-102
Ito M, Karachot L. 1989. Long-term desensi-
tization of quisqualate-specific glutamate re-
ceptors in Purkinje cells investigated with
wedge recordings from rat cerebellar slices.
Neurosci. Res. 458:397-401
Ito M, Karachot L. 1990. Messengers mediat-
ing long-term desensitization in cerebellar
Purkinje cells. NeuroReport 1 : 129-32
Ito M, Sakurai M, Tongroach P. 1982. Climb-
ing fiber induced depression of both mossy
fibre responsiveness and glutamate sensitiv-
ity of cerebellar Purkinje cells. J. Physiol.
324:113-24
Izumi Y, Clifford DB, Zorumski CF. 1992.
Inhibition of long-term potentiation by
NMDA-mediated nitric oxide release. Sci-
ence 257:1273-76
Jahr CE, Stevens CF. 1987. Glutamate acti-
vates multiple single channel conductances
in hippocampal neurones. Nature 325:522-
25
Janssens SP, Shimouchi A, Quertermous T, et
al. 1992. Cloning and expression of a cDNA
encoding human endothelium-derived relax-
ing factor/nitric oxide synthase. J. Biol.
Chem. 267:14519-22
Kandel ER, O’Dell TJ. 1992. Are adult learn-
ing mechanisms also used for development?
Science 258:243-45
Kaplan JM, Mardon G, Bishop JM, Varmus
HE. 1988. The first seven amino acids
encoded by the v-src oncogene act as a
myristylation signal: lysine 7 is a critical
determinant. Mol. Cell. Biol. 8:2435-41
Kawano H, Daikoku S, Shibasaki T. 1988.
CRF-containing neuron systems in the rat
hypothalamus: retrograde tracing and im-
munohistochemical studies. J. Comp. Neu-
rol. 272:260--68
Kiedrowski L, Costa E, Wroblewski JT. 1992.
Sodium nitroprusside inhibits N-methyl-D-
aspartate-evoked calcium influx via a nitric
oxide- and cGMP independent mechanism.
M ol. P harmaco~. 41:779-84
Kiedrowski L, Manev H, Costa E, Wroblewski
JT. 1991. Inhibition of glutamate-induced
cell death by sodium nitroprusside is not
mediated by nitric oxide. Neuropharmacol-
ogy 30:1241-43
Knowles RG, Palacios M, Palmer RMG,
Moncada S. 1989. Formation of nitric oxide
from L-arginine in the central nervous sys-
tem: a transduction mechanism for stimula-
www.annualreviews.org/aronline
Annual Reviews
A
nn
u.
 R
ev
. N
eu
ro
sc
i. 
19
94
.1
7:
15
3-
18
3.
 D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
NO AND SYNAPTIC FUNCTION 181
tion of soluble guanylate cyclase, Proc.
Natl. Acad. Sci. USA 86:5159-62
Koh J-Y, Peters S, Choi DW. 1986. Neurons
containing NADPH-diaphorase are selec-
tively resistant to quinolate toxicity. Science
234:73-76
Kossel A, Bonhoeffer T, Bolz J. 1990. Non-
Hebbian synapses in rat visual cortex. Neu-
roReport 1:115-18
Kots AY, Skurat AV, Sergienko EA, et
al. 1992. Nitroprusside stimulates the
cysteine-specific mono(ADP-ribosylation) 
glyceraldehyde-3-phosphate dehydrogenase
from human erythrocytes. FEBS Lett.
300:9-12
Kullmann DM, Nicoll RA. 1992. Long-term
potentiation is associated with increases in
quantal content and quantal amplitude. Na-
ture 357:240-44
Lamas S, Marsden PA, Li GK, et al, 1992.
Endothelial nitric oxide synthase: molecular
cloning and characterization of a distinct
constitutive enzyme isoform. Proc. Natl.
Acad. Sci. USA 89:6348-52
Larkman A, Hannay T, Stratford K, Jack J.
1992. Presynaptic release probability influ-
ences the locus of long-term potentiation.
Nature 360:70-73
Lazarewicz JW, Wroblewski JT, Palmer ME,
Costa E. 1989. Reduction of disulfide bonds
activates NMDA-sensitive glutamate recep-
tors in primary cultures of cerebellar granule
cells. Neuros¢i. Res Commun. 4:91-97
Lei SZ, Pan Z-H, Aggarwal SK, et al. 1992.
Effect of nitric oxide production on the redox
modulatory site of the NMDA receptor-
channel complex. Neuron 8:1087-99
Lerner-Natoli M, Rondouin G, deBock F,
Bockaert J. 1992. Chronic NO synthase
inhibition fails to protect hippocampal neu-
rones against NMDA toxicity. NeuroReport
3:1109-12
Li YG, Errington ML, Williams JH, Bliss
TVP. 1992. Temperature-dependent block
of LTP by the NO synthase inhibitor L-
NARG. Soc. Neurosci. Abstr. 18:342
Linden D J, Connor JA. 1991. Participation of
postsynaptic PKC in cerebellar long-term
depression in culture. Science 254:1656-59
Linden DJ, Connor JA. 1992. Long-term de-
pression of glutamate currents in cultured
cerebellar purkinje neurons does not require
nitric oxide signalling. Eur. J. Neurosci.
4:10-15
Linden DJ, Dickinson MH, Smeyne M, Con-
nor JA. 1991. A long-term depression of
AMPA currents in cultured cerebellar
Purkinje neurons. Neuron 7:81-89
Lohmann SM, Walter U, Miller PE, et al.
1981. Immunohistochemical localization of
cyclic GMP-dependent protein kinase in
mammaliam brain. Proc. Natl. Acad. Sci.
USA 78:653-57
Lonart G, Wang J, Johnson KM. 1992. Nitric
oxide induces neurotransmitter release from
hippocampal slices. Eur. J. Pharmacol. 220:
271-72
Lovinger DM, Wong KL, Murakami K,
Routtenberg A. 1987. Protein kinase C in-
hibitors eliminate long-term potentiation.
Brain Res. 436:177-83
Lowenstein CJ, Glatt CS, Bredt DS, Snyder
SH. 1992. Cloned and expressed macro-
phage nitric oxide synthase contrasts with
the brain enzyme. Proc. Natl. Acad. Sci.
USA 89:6711-15
Lustig HS, von Brauchitsch KL, Chan J,
Greenberg DA. 1992. cGMP modulators and
excitotoxic injury in cerebral cortical cul-
tures. Brain Res. 577:343~,6
Lynch G, Baudry M. 1984. The biochemistry
of memory: a new and specific hypothesis.
Science 224:1057-63
Lynch G, Larson J, Kelso S, et al. 1983.
Intracellular injections of EGTA block in-
duction of hippocampal long-term potentia-
tion. Nature 305:719-21
Lyons CR, Orloff GJ, Cunningham JM. 1992.
Molecular cloning and functional expression
of an inducible nitric oxide synthase from a
murine macrophage cell line. J. Biol. Chem.
267:6370-74
MacDermott AB, Mayer ML, Westbrook GL,
et al. 1986. NMDA-receptor activation in-
creases cytoplasmic calcium concentration
in cultured spinal cord neurones. Nature
321:519-22
Madison DV, Malenka RC, Nicoll RA. 1991.
Mechanisms underlying long-term potentia-
tion of synaptic transmission. Annu. Rev.
Neurosci. 14:379-97
Malenka RC, Kauer JA, Perkel DJ, et al. 1989.
An essential role for postsynaptic calmodulin
and protein kinase activity in long-term
potentiation. Nature 340:554-57
Malenka RC, Kauer JA, Zuker R J, Nicoll RA.
1988. Postsynaptic calcium is sufficient for
potentiation of hippocampal synaptic trans-
mission. Science 242:81-84
Malgaroli A, Tsien RW. 1992. Glutamate-in-
duced long-term potentiation of the fre-
quency of miniature synaptic currents in
cultured hippocampal neurones. Nature 357:
134-39
Malinow R. 1991. Transmission between pairs
of hippocampal slice neurons: quantal levels,
oscillations and LTP. Science 252:722-24
Malinow R, Madison DV, Tsien RW. 1988.
Persistent protein kinase activity underlies
long-term potentiation. Nature 335:820-24
Malinow R, Miller JP. 1986. Postsynaptic
hyperpolarization during conditioning re-
versibly blocks induction of long-term po-
tentiation. Nature 320:529-30
Malinow R, Schulman R, Tsien RW. 1989.
Inhibition of postsynaptic PKC or CAMKII
www.annualreviews.org/aronline
Annual Reviews
A
nn
u.
 R
ev
. N
eu
ro
sc
i. 
19
94
.1
7:
15
3-
18
3.
 D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
182 SCHUMAN & MADISON
blocks induction but not expression of LTP.
Science 245:862-66
Malinow R, Tsien RW. 1990. Presynaptic
enhancement shown by whole-cell record-
ings of long-term potentiation in hippocam-
pal slices. Nature 346:177-80
Manabe T, Renner P, Nicoll RA. 1992. Post-
synaptic contribution to long-term potentia-
tion revealed by the analysis of miniature
synaptic currents. Nature 355:50-55
Manzoni O, Prezeau L, Deshager S, et al.
1992a. Sodium nitroprusside blocks NMDA
receptors via formation of ferrocyanide ions.
NeuroReport 3:77-80
Manzoni O, Prezeau L, Marin P, et al. 1992b.
Nitric oxide-induced blockade of NMDA
receptors. Neuron 8:653-62
Marietta MA. 1989. Nitric oxide: biosynthesis
and biological significance. Trends Biol. Sci.
14:488-92
Marsden PA, Schappert KT, Chert HS, et al.
1992. Molecular cloning and characteriza-
tion of human endothelial nitric oxide syn-
thase. FEBS Lett. 307:287-93
Mayer ML, Westbrook GL. 1987. Permeation
and block of N-methyl-D-aspartic acid
receptor channels by divalent cations in
mouse central neurones. J. Physiol. 394:
501-28
McCormick DA, Thompson RF. 1984. Cere-
bellum: essential involvement in the classi-
cally conditioned eyelid response. Science
223:296-99
Miki N, Kawabe Y, Knriyama K. 1977. Acti-
vation of cerebral guanylate cyclase by nitric
oxide. Biochem. Biophys. Res. Commun.
75:851-56
Molina y Vedia L, McDonald B, Reep B, et
al. 1992. Nitric oxide-induced S-nitrosyla-
tion of glyceraldehyde-3-phosphate dehydro-
genase inhibits enzyme activity and increase
endogenous ADP-ribosylation. J. Biol.
Chem. 267:24929-32
Mizukawa K, Vincent SR, McGeer PL,
McGeer EG. 1988. Ultrastructure of reduced
nicotinamide dinucleotide phosphate
(NADPH) diaphorase- positive neurons 
the cat cerebral cortex, amygdala and cau-
date putamen. Brain Res. 452:286-92
Montague PR, Gaily JA, Edelman GM. 1991.
Spatial signaling in the development and
function of neural connections. Cereb. Cor-
tex 1:199-220
Morris RGM. 1984. Development of a water
maze procedure for studying spatial learning
in the rat. J. Neurosci. Meth. 11:47-60
Morris RGM, Anderson E, Lynch GS, Baudry
M. 1986, Selective impairment of learning
and blockade of long-term potentiation by an
N-methyl-D-aspartate receptor antagonist
AP5. Nature 319:774-76
Morris RGM, Schenk F, Tweedie F, Jarrard L.
1990. Ibotenate lesions of the hippocampus
and/or subiculum: dissociating components
of allocentric spatial learning. Eur. J. Neu-
rosci. 2:1016-28
Murad F, Mittal CK, Arnold WP, et al. 1978.
Guanylate cyclase: activation by azide, nitro
compounds, nitric oxide, and hydroxyl rad-
ical and inhibition by hemoglobin and myo-
globin. Adv. Cyclic Nucl. Res. 9:145-58
Nakaki T, Nakayama M, Kato R. 1990. Inhi-
bition by nitric oxide and nitric oxide-pro-
ducing vasodilators of DNA synthesis in
vascular smooth muscle cells. Eur. J. Phar-
macol. 189:347-53
Nakane M, Ichikawa M, Deguchi T. 1983.
Light and electron microscopic demonstra-
tion of guanylate cyclase in rat brain. Brain
Res. 273:9-15
Nakane M, Mitchell J, Forstermann U, Murad
F. 1991. Phosphorylation by calcium-calmo-
dulin-dependent protein kinase II and protein
kinase C modulates the activity of nitric
oxide synthase. Biochem. Biophys. Res.
Comtnun. 180:1396-402
Nowak L, Bregestovski P, Ascher P, et al.
1984. Magnesium gates glutamate-activated
channels in mouse central neurones. Nature
307:462-65
Nowicki JP, Duval D, Poignet H, Scatton B.
1991. Nitric oxide mediates neuronal death
after focal cerebral ischemia in the mouse.
Eur. J. Pharmacol. 204:339-40
O’Dell TJ, Hawkins RD, Kandel ER, Arancio
O. 1991. Tests on the roles of two
diffusible substances in LTP: evidence
for nitric oxide as a possible early
retrograde messenger. Proc. Natl. Acad.
Sci. USA 88:11285-89
Palmer RMJ, Ferrige AG, Moncada S. 1987.
Nitric oxide accounts for the biological ac-
tivity of endothelium-derived relaxing fac-
tor. Nature 327:524-26
Pauwels P, Leysen JE. 1992. Blockade of nitric
oxide formation does not prevent glutamate-
induced neurotoxicity in neuronal cultures
from rat hippocampus. Neuros¢i. Lett. 143:
27-30
Peunova N, Enikolopov G. 1993. Amplifica-
tion of calcium-induced gene transcription
by nitric oxide in neuronal cells. Nature.
364:450-53
Pollock JS, F6rstermann U, Mitchell JA,
Wamer TA, Schmidt HHHW, et a|. 1991.
Purification and characterization of particu-
late endothelium-derived relaxing factor syn-
thase from cultured and native bovine aortic
endothelial cells. Proc. Natl. Acad. Sci. USA
88:10480--84
Pollock JS, Klinghofer V, Forstermann U,
Murad F. 1992. Endothelial nitric oxide
synthase is myristylated. FEBS Lett. 309:
402~-
Prast H, Phillipu A. 1992. Nitric oxide releases
acetylcholine in the basal forebrain. Eur. J.
Pharmacol. 216:139-40
Puttfarcken PS, Lyons WE, Coyle JT. 1992.
www.annualreviews.org/aronline
Annual Reviews
A
nn
u.
 R
ev
. N
eu
ro
sc
i. 
19
94
.1
7:
15
3-
18
3.
 D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
NO AND SYNAPTIC FUNCTION 183
Dissociation of nitric oxide generation and
lainiate-mediated neuronal degeneration in
primary cultures of rat cerebellar granule
cells. Neuropharmacology 31:565-75
Rajfer J, Aronson WJ, Bush PA, et al. 1992.
Nitric oxide as a mediator of the corpus
cavernosum in response to nonadrenergic
non cholinergic transmission. N. Engl, J.
Med. 326:90-94
Rapoport RM, Draznin MB, Murad F. 1983.
Endothelium-dependent relaxation in rat
aorta may be mediated through cGMP-de-
pendent phosphorylation. Nature 306:174-
76
Rashatwar SS, Comwell TL, Lincoln TM.
1987. Effects of 8-bromo-cGMP on Cae+
levels in vascular smc~oth muscle cells: pos-
sible regulation of Cae+-ATPase by cGMP-
dependent protein kinase. Proc. Natl. Acad.
Sci. USA 84:5685-89
Schmidt HHHW Pollock JS Nakane M et al.2÷~ , ,1992. Ca /calmodulin-regulated nitric
oxide synthases. Cell Calcium 13:427-34
Schuman EM, Madison DV. 1991 a. A require-
ment for the intercellular messenger nitric
oxide in long-term potentiation. Science 254:
1503-6
Schuman EM, Madison DV. 1991b. An inhib-
itor of nitric oxide synthase prevents long-
term potentiation (LTP). Soc. Neurosci.
Abstr. 17:2
Schuman EM, Madison DV. 1993. Long-term
potentiation induced in a single CA1 pyram-
idal neuron can enhance nearby, but not
distant, synapses. Soc. Neurosci. Abstr, In
press
Schuman EM, Meffert MK, Schulman H,
Madison DV. 1992. A potential role for an
ADP-ribosyltransferase in hippocampal
long-term potentiation. Soc. Neurosci.
Abstr. 18:761
Schweizer FE, Wendland B, Ryan TA, et al.
1993. Evidence for the presence of nitric
oxide synthase in rat hippocampal pyramidal
cells. Soc. Neurosci. Abstr. In press
Sessa WC, Harrison IK, Barber CM, et al.
1992. Molecular cloning and expression of
a cDNA encoding endothelial cell nitric
oxide synthase. J. Biol. Chem. 267:15274-
76
Shibuki K, Okada D. 1990. Long-term synap-
tic changes in rat cerebellar slices reflected
in extracellular K+ activity. Neurosci. Lett.
113:34-39
Shibuki K, Okada D, 1991. Endogenous nitric
oxide release required for long-term synaptic
depression in the cerebellum. Nature 349:
326-28
Silva AJ, Stevens CF, Tonegawa S, Wang Y.
1992. Deficient hippocampal long-term po-
tentiation in a-calcium-calmodulin kinase II
mutant mice. Science 257:201-6
Southam E, Garthwaite J. 1991, Comparative
effects of some nitric oxide donors on cyclic
GMP levels in rat cerebellar slices. Neu-
rosci. Lett. 130:107-11
Stuehr DJ, Marietta MA. 1987. Induction of
nitrite/nitrate synthesis in murine macro-
phages by BCG infection, lymphokines, or
interferon ~. J. lmmunol. 139:518-25
Tauck DL. 1992. Redox modulation of NMDA
receptor-mediated synaptic activity in the
hippocampus. NeuroReport 3:781-84
Ueda K, Hayaishi O. 1985. ADP-ribosylation.
Annu. Rev. Biochem. 54:73-100
Valtschanoff JG, Weinberg RJ, Kharazia VN,
et al. 1993. Neurons in the rat hippocampus
that synthesize nitric oxide. J. Comp. Neu-
rol. 330: l-l l
Verma A, Hirsch DJ, Glatt CE, et al. 1993.
Carbon monoxide: a putative neural messen-
ger. Science 259:381-84
Vincent SR, Johansson O, Hokfelt T, et al.
1983.NADPH-diaphorase: a selective histo-
chemical marker for striatal neurons contain-
ing both somatostatin- and avian pancreatic
polypeptide (APP)-like immunoreactivities.
J. Comp. Neurol. 217:252-63
Wallace MN, Fredens K. 1992. Activated
astrocytes of the mouse hippocampus contain
high levels of NADPH-diaphorase. Neu-
roReport 3:953-56
Williams JH, Errington ML, Bliss TVP. 1989.
Arachidonic acid induces a long-term activ-
ity-dependent enhancement of synaptic
transmission in the hippocampus. Nature
341:739-42
Williams MB, Li X, Gu X, Jope RS. 1992.
Modulation of endogenous ADP-ribosyla-
tion in rat brain. Brain Res. 592:49-56
Wolin MS, Wood KS, Ignarro LJ. 1982.
Guanylate cyclase from bovine lung. A ki-
netic analysis of the regulation of unpurified
soluble enzyme by protoporphyrin IX, heme,
and nitrosyl-heme. J. Biol. Chem. 257:
11312-20
Xie Q, Cho HJ, Calayeay J, et al. 1992.
Cloning and characterization of inducible
nitric oxide synthase from mouse macro-
phages. Science 256:225-28
Zhang J, Snyder SH. 1992. Nitric oxide stim-
ulates auto-ADP-ribosylation of glyceralde-
hyde-3-phosphate dehydrogenase. Proc.
Natl. Acad. Sci. USA 89:9382-85
Zhou M, Small SA, Kandel ER, Hawkins RD.
1993. Nitric oxide and carbon monoxide
produce long-term enhancement of synaptic
transmission in the hippocampus by an ac-
tivity-dependent mechanism. Science 260:
1946-49
Zhu XZ, Luo LG. 1992. Effect of nitroprusside
(nitric oxide) on endogenous dopamine re-
lease from rat striatal slices. J. Neurochem.
59:932-35
Zoccarato F, Deana R, Cavallini L, Alexandre
A. 1989. Generation of hydrogen peroxide
by cerebral-cortex synaptosomes. Eur. J.
Biochem. 180:473-78
www.annualreviews.org/aronline
Annual Reviews
A
nn
u.
 R
ev
. N
eu
ro
sc
i. 
19
94
.1
7:
15
3-
18
3.
 D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
A
nn
u.
 R
ev
. N
eu
ro
sc
i. 
19
94
.1
7:
15
3-
18
3.
 D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
A
nn
u.
 R
ev
. N
eu
ro
sc
i. 
19
94
.1
7:
15
3-
18
3.
 D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
